Literature DB >> 12406091

CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells.

Hervé Husson1, Arnold S Freedman, Angelo A Cardoso, Joachim Schultze, Olivier Munoz, Giuliana Strola, Jeffery Kutok, Elizabeth G Carideo, Rosalie De Beaumont, Federico Caligaris-Cappio, Paolo Ghia.   

Abstract

Follicular lymphomas (FLs) localize in lymphoid tissues and recapitulate the structure of normal secondary follicles. The chemokine/chemokine receptor pair CXCL13/CXCR5 is required for the architectural organization of B cells within lymphoid follicles. In this study, we showed that CXCL13 was secreted by FL cells. FL cells expressed CXCR5 and migrated in response to CXCL13. Furthermore, we observed a synergistic effect between CXCL13 and CXCL12 (SDF-1), a chemokine produced by stromal cells in lymphoid tissues. The production of CXCL13 by FL cells and CXCL12 by stromal cells probably directs and participates in the accumulation of FL cells within specific anatomic sites.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406091     DOI: 10.1046/j.1365-2141.2002.03832.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  17 in total

Review 1.  The host-tumor interface in B-cell non-Hodgkin lymphoma: a new world to investigate.

Authors:  Nicolas Rachinel; Gilles Salles
Journal:  Curr Hematol Malig Rep       Date:  2009-10       Impact factor: 3.952

Review 2.  The role of G protein-coupled receptors in lymphoid malignancies.

Authors:  Adrienne Nugent; Richard L Proia
Journal:  Cell Signal       Date:  2017-08-09       Impact factor: 4.315

3.  Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate Cancer.

Authors:  Christelle P El-Haibi; Rajesh Singh; Pranav Gupta; Praveen K Sharma; Krysta N Greenleaf; Shailesh Singh; James W Lillard
Journal:  J Proteomics Bioinform       Date:  2012

4.  Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial).

Authors:  Marta Epeldegui; Jeannette Y Lee; Anna C Martínez; Daniel P Widney; Larry I Magpantay; Deborah Regidor; Ronald Mitsuyasu; Joseph A Sparano; Richard F Ambinder; Otoniel Martínez-Maza
Journal:  Clin Cancer Res       Date:  2015-09-17       Impact factor: 12.531

5.  Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.

Authors:  Shehnaz K Hussain; Weiming Zhu; Shen-Chih Chang; Elizabeth Crabb Breen; Elena Vendrame; Larry Magpantay; Dan Widney; Daniel Conn; Mary Sehl; Lisa P Jacobson; Jay H Bream; Steven Wolinsky; Charles R Rinaldo; Richard F Ambinder; Roger Detels; Zuo-Feng Zhang; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-18       Impact factor: 4.254

6.  A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma.

Authors:  Mark P Purdue; Jonathan N Hofmann; Troy J Kemp; Anil K Chaturvedi; Qing Lan; Ju-Hyun Park; Ruth M Pfeiffer; Allan Hildesheim; Ligia A Pinto; Nathaniel Rothman
Journal:  Blood       Date:  2013-06-27       Impact factor: 22.113

Review 7.  Homeostatic chemokines guide lymphoma cells to tumor growth-promoting niches within secondary lymphoid organs.

Authors:  Uta E Höpken; Armin Rehm
Journal:  J Mol Med (Berl)       Date:  2012-05-11       Impact factor: 4.599

8.  Stromal cell contribution to human follicular lymphoma pathogenesis.

Authors:  Frédéric Mourcin; Céline Pangault; Rada Amin-Ali; Patricia Amé-Thomas; Karin Tarte
Journal:  Front Immunol       Date:  2012-09-05       Impact factor: 7.561

9.  Entourage: the immune microenvironment following follicular lymphoma.

Authors:  B E Wahlin; B Sander; B Christensson; B Ostenstad; H Holte; P D Brown; C Sundström; E Kimby
Journal:  Blood Cancer J       Date:  2012-01-20       Impact factor: 11.037

10.  Interleukin-2 Functions in Anaplastic Large Cell Lymphoma Cells through Augmentation of Extracellular Signal-Regulated Kinases 1/2 Activation.

Authors:  Masanori Ito; Nianxi Zhao; Zihua Zeng; Xiaobo Zhou; Chung-Che Chang; Youli Zu
Journal:  Int J Biomed Sci       Date:  2011-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.